QICE Capital Partners

QCP is committed to bridging the GAPs between Asia and Global disruptive AI/deeptech companies, advanced healthcare & wellness companies & creative consumer brands by introducing sales/investors channels as well as helping new generation of Chinese companies expanding overseas. Focused overseas markets are US/Israel, Europe/UK, Australia/Japan, MENA/Africa, etc.

QCP generally works with mid-to-late stage tech, consumer and healthcare companies by maximizing their strategic premium by empowering them with business development, next-round private-equity/debt fundraising, liquidity planning and exit optimization. 

Our investor-base are mostly Asia & Global top family offices, listed corps decision-makers and UHNWIs, which gives QCP elite access to proprietary deal-flows and ecosystem of opportunities for direct investment. We only invest 3-6 months post monitoring the companies cooperating with us through our investment banking/financial advisory activities.

QCP focuses on direct investment opportunities from pre-seed, angel, growth to late stage companies in Asia (40%) & US/Europe/Israel(60%). We as well remain a curious alternative fund manager exploring proprietary opportunities in hedge fund, real estate and crypto investment with high emphasis on steadily alpha return to our investment partners.

QCP has built vast Asian & Global founders, elite business leaders & investors network (30,000+ VIPs) for co-investment opportunities. We're in the process of mapping out our 1st institutional fund HUO in the context of AI-revolutionized alternative investment worlds aiming to offer the best-in-class annual return for our 1st batch of institutional fund investors.

Our entire model centers around adding significant value to our portfolio companies globally. We leverage deep & curated relationships with top industry leaders in tech, consumer & healthcare areas to offer active operational advice as means to gain exclusive deal access and extra returns for our shareholders.